Get started
Author

Majid Farrokhifar

Observed names: Farrokhifar M, Farrokhifar, Majid
ORCID: 0000-0003-2174-7165
Observed ORCID: 0000-0003-2174-7165
OpenAlex ID: A5048484048
Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study
2020 · Hadi Zare-Zardini, Ashraf Alemi, et al. · Drug Design Development and Therapy · 43
PDF
A Comparison between the Anticancer Activities of Free Paclitaxel and Paclitaxel-Loaded Niosome Nanoparticles on Human Acute Lymphoblastic Leukemia Cell Line Nalm-6
2018 · Ashraf Alemi, Majid Farrokhifar, et al. · Iranian Journal of Pediatric Hematology & Oncology · 7
Co‐encapsulation of Curcumin and Paclitaxel using Non‐ionic Surfactant Based Nanovesicles Suppresses Growth of Ovarian Carcinoma through the Inhibition of Nuclear Factor κB and AKT1
2024 · Mojtaba Haghi Karamallah, Ashraf Alemi, et al. · ChemistrySelect · 4
Design of a New Coating Agent Based on Graphene Oxide and Antimicrobial/Spermicidal Peptide (Sarcotoxin Pd) for Condom Coating: New Strategy for Prevention of Unplanned Pregnancy and Sexually Transmitted Infections
2023 · Hadi Zare-Zardini, Ashraf Alemi, et al. · Journal of Nanomaterials · 3
PDF
Combined Therapy for Paclitaxel and Curcumin by Nonionic Surfactant Vesicles Leading to Enhanced Efficacy of Chemotherapy in Ovarian Cancer Cells Through Inhibiting the Serine/threonine Kinase Akt and Nuclear Factor Kappab Activity
2021 · ashraf alemi, Mojtaba Haghi Karamallah, et al. · Research Square · 1
PDF
Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study
2020 · Zare-Zardini H, Alemi A, et al. · DOAJ (DOAJ: Directory of Open Access Journals)
Works count: 9
Citation count: 59
H-index: 3
I10-index: 1
Year
Topic
Type